UFINEOM Trademark

Trademark Overview

On Monday, July 28, 2014, a trademark application was filed for UFINEOM with the United States Patent and Trademark Office. The USPTO has given the UFINEOM trademark a serial number of 86349849. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 15, 2023. This trademark is owned by Glaxo Group Limited. The UFINEOM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
ufineom

General Information

Serial Number86349849
Word MarkUFINEOM
Filing DateMonday, July 28, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 15, 2023
Registration Number5211521
Registration DateTuesday, May 30, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 7, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "Ufineom" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Friday, December 15, 2023CANCELLED SEC. 8 (6-YR)
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, May 30, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 30, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, April 25, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, March 1, 2017NOTICE OF ALLOWANCE CANCELLED
Wednesday, March 1, 2017TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 25, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 24, 2016SOU EXTENSION 2 GRANTED
Monday, August 15, 2016SOU EXTENSION 2 FILED
Monday, August 15, 2016SOU TEAS EXTENSION RECEIVED
Saturday, March 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 18, 2016SOU EXTENSION 1 GRANTED
Thursday, February 11, 2016SOU EXTENSION 1 FILED
Monday, March 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 11, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, September 1, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 7, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 7, 2015PUBLISHED FOR OPPOSITION
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 17, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 4, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 3, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 2, 2015DATA MODIFICATION COMPLETED
Monday, May 11, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 11, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 4, 2015ASSIGNED TO LIE
Thursday, April 30, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, November 12, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 12, 2014LETTER OF SUSPENSION E-MAILED
Wednesday, November 12, 2014SUSPENSION LETTER WRITTEN
Monday, November 10, 2014ASSIGNED TO EXAMINER
Tuesday, August 5, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 31, 2014NEW APPLICATION ENTERED

Related Keywords

ufineom pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological